Financials

News Discussions Technicals Forecast

MAZE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Maze Therapeutics, Inc. operating, investing, and financing activities

MAZE free cash flow for Q1 25 is -29.82 M USD. For 2024, MAZE free cash flow was 74.81 M USD and operating cash flow was 75.95 M USD.

Q3 '23

Q4 '23

Q1 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '23

Q4 '23

Q1 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—